IRD

Opus Genetics, Inc. IRD

IRD
Opus Genetics, Inc. ABOS
Acumen Pharmaceuticals, Inc. SEER
Seer, Inc. AGEN
Agenus Inc. INO
Inovio Pharmaceuticals, Inc. VTGN
VistaGen Therapeutics, Inc. HURA
TuHURA Biosciences, Inc. ALEC
Alector, Inc. CGTX
Cognition Therapeutics, Inc. TIL
Instil Bio, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode IRD ABOS SEER AGEN INO VTGN HURA ALEC CGTX TIL
6M 121.13 % 91.59 % -12.32 % -20.85 % 13.75 % 99.10 % -61.03 % -7.79 % 444.75 % -67.54 %
YTD 70.24 % 10.81 % -22.10 % 20.39 % 25.00 % 32.53 % -76.68 % -24.87 % 124.73 % -48.61 %
1Y 114.50 % 4.06 % -26.81 % 31.45 % 5.81 % 77.42 % -76.85 % -28.28 % 260.31 % -50.62 %
3Y 66.28 % -61.10 % -71.28 % -92.38 % -89.23 % 33.33 % -89.59 % -83.94 % -37.98 % -4.21 %
5Y 66.28 % -89.80 % -97.26 % -94.96 % -98.26 % -81.20 % -98.59 % -90.68 % -87.27 % -97.90 %
10Y 66.28 % -89.80 % -96.79 % -95.26 % -96.97 % -97.21 % -99.96 % -92.11 % -87.27 % -97.90 %
From the beginning 66.28 % -89.80 % -96.79 % -99.95 % -99.68 % -99.70 % -99.97 % -92.11 % -87.27 % -97.90 %

Dividend

Inovio Pharmaceuticals, Inc.